MARKET

ONVO

ONVO

Organovo
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3294
+0.0395
+13.63%
After Hours: 0.3000 -0.0294 -8.93% 17:58 04/08 EDT
OPEN
0.2801
PREV CLOSE
0.2899
HIGH
0.3329
LOW
0.2621
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
1.050
52 WEEK LOW
0.1933
MARKET CAP
42.99M
P/E (TTM)
-1.8059
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ONVO stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.

EPS

ONVO News

More
  • The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
  • Benzinga · 10h ago
  • The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
  • Benzinga · 11h ago
  • Edited Transcript of ONVO earnings conference call or presentation 9-Nov-17 10:00pm GMT
  • Thomson Reuters StreetEvents · 15h ago
  • Organovo stockholders nix Tarveda merger; shares up 2% after hours
  • seekingalpha · 21h ago

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About ONVO

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products, including 3D human tissues used for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion (ADME), and drug metabolism and pharmacokinetics (DMPK); customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development, and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair and functional tissue patches for the repair or replacement of damaged tissues and organs.
More

Webull offers kinds of Organovo Holdings Inc stock information, including NASDAQ:ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions.